Post Archive by Day

Slight reduction seen in major cardiovascular events; very low certainty of serious adverse events reported

Lower risk for clinically relevant bleeding seen in acute coronary syndrome, with no increase in risk for MACCE

Lower risks for first heart failure hospitalization, total heart failure hospitalization seen with empagliflozin

Higher baseline Digital AS Severity index associated with faster progression in aortic valve velocity